What are the manifestations and treatment options for Lyme disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Manifestations of Lyme Disease

Lyme disease presents with a wide spectrum of clinical manifestations that can be categorized into three stages: early localized, early disseminated, and late disease, with each stage having distinct clinical features.

Early Localized Stage (Days to Weeks After Infection)

  • Erythema migrans (EM) - The pathognomonic skin rash occurs in 80% of patients, typically 7-14 days after the tick bite (range 3-30 days). It appears as an expanding red macule or papule that can grow to >20 cm in diameter, often with central clearing 1, 2
  • Flu-like symptoms - Fever, malaise, fatigue, headache, myalgia, and arthralgia often accompany the rash 1, 2
  • Some patients may have asymptomatic infection with no recognized illness 1

Early Disseminated Stage (Days to Months After Infection)

Cutaneous Manifestations

  • Multiple erythema migrans lesions - Secondary skin lesions appearing days to weeks after initial infection, indicating hematogenous spread 1, 2
  • Borrelial lymphocytoma - A rare cutaneous manifestation in Europe presenting as a solitary bluish-red swelling, commonly on the ear lobe in children or breast/nipple area in adults 1, 2

Neurologic Manifestations (Neuroborreliosis)

  • Lymphocytic meningitis - Presenting with headache and neck stiffness 1
  • Cranial neuropathy - Especially facial nerve palsy, which may be bilateral 1
  • Radiculoneuritis - Motor or sensory radiculopathy, often presenting as shooting pains 1
  • These three neurological manifestations together are known as Bannwarth syndrome in Europe 3

Cardiac Manifestations

  • Atrioventricular heart block - Varying degrees of intermittent heart block, often occurring above the bundle of His 1
  • Myopericarditis - Can occur in association with heart block 1
  • Cardiac involvement is relatively rare (historically reported in 4-10% of untreated patients, but much lower in recent series) 1
  • Not associated with severe congestive heart failure or valvular heart disease 1

Musculoskeletal Manifestations

  • Migratory joint and muscle pains - With or without objective joint swelling 1

Late Disseminated Stage (Months to Years After Infection)

Musculoskeletal Manifestations

  • Lyme arthritis - Intermittent swelling and pain of one or several large joints (especially knees), which can persist for weeks to months 1
  • Approximately 10% of patients may develop persistent joint swelling even after appropriate antibiotic treatment 1

Neurologic Manifestations

  • Chronic axonal polyneuropathy - Presenting with sensory disturbances 1
  • Encephalopathy - Manifested by cognitive disorders, sleep disturbance, fatigue, and personality changes 1

Cutaneous Manifestations

  • Acrodermatitis chronica atrophicans (ACA) - A late skin manifestation primarily seen in Europe, characterized by skin atrophy typically on the extensor surfaces of hands and feet 3, 2
  • Due to skin atrophy, veins may become prominent, potentially leading to misdiagnosis as venous insufficiency 3

Post-Treatment Lyme Disease Syndrome

  • Some patients experience persistent subjective symptoms (fatigue, arthralgia, myalgia) after appropriate antibiotic treatment 1
  • The frequency of these symptoms decreases over time - from approximately 35% at 20 days post-treatment to 17% at 12 months 1
  • These symptoms may be due to slow resolution of inflammation, residual damage, or other factors 1

Diagnostic Considerations

  • Clinical diagnosis is primarily based on clinical findings, especially for early disease with erythema migrans 1
  • Serologic testing (two-tier approach with ELISA followed by Western blot) is valuable for later-stage disease 1
  • Antibodies often persist for months or years after successfully treated infection, so seropositivity alone cannot indicate active disease 1

Treatment Approach

  • Early localized or early disseminated disease with erythema migrans: Oral antibiotics for 14 days

    • Doxycycline (100 mg twice daily)
    • Amoxicillin (500 mg three times daily)
    • Cefuroxime axetil (500 mg twice daily) 1
  • Neurologic manifestations: Ceftriaxone 2g IV once daily for 14 days (range 10-28 days) 1

  • Cardiac manifestations: Oral or parenteral antibiotics for 14 days (range 14-21 days); hospitalization and monitoring recommended for symptomatic patients or those with advanced heart block 1

  • Lyme arthritis: Oral antibiotics for 28 days; persistent arthritis may require a second course or other approaches 1

Important Clinical Pitfalls

  • Not all patients recall a tick bite (only about 25%) 3
  • Coinfection with other tick-borne pathogens should be considered in patients with more severe initial symptoms, especially high-grade fever persisting >48 hours despite appropriate antibiotics 1
  • Macrolide antibiotics are less effective and should only be used when patients cannot tolerate first-line agents 1
  • Persistent symptoms after treatment do not necessarily indicate ongoing infection and may not benefit from additional antibiotics 1
  • Lyme disease is rarely, if ever, fatal 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical spectrum of Lyme disease.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019

Research

Skin Changes in Suspected Lyme Disease.

Acta dermatovenerologica Croatica : ADC, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.